Banerjee et al. reported that compared to brassing alone, which did not influence the growth of the B16-F10 tumor, treatment of its derivative (5-bromo-brassinin) could induce tumor extinction via active host T cell immunity by inhibiting IDO [97], providing a new suggestion of using natural products as lead compounds for drug exploration. This evidence concerns the gene IDO1 and neoplasm.